Literature DB >> 7473553

N-acylated alpha-amino acids as novel oral delivery agents for proteins.

A Leone-Bay1, N Santiago, D Achan, K Chaudhary, F DeMorin, L Falzarano, S Haas, S Kalbag, D Kaplan, H Leipold.   

Abstract

A series of N-acylated alpha-amino acids were synthesized and shown to improve the oral delivery of two protein drugs, salmon calcitonin (sCT) and interferon-alpha. Forty-five compounds in this series were tested in vivo in rats and primates. A significant positive correlation was found between the log P of the acylated amino acids and the decrease in serum calcium following oral dosage of sCT in rats. Such a correlation was not found for interferon-alpha. These derivatized amino acids only weakly inhibited the activity of trypsin or leucine aminopeptidase. Histological examinations of rat intestinal tissue after oral dosing of acylated amino acid/protein combinations revealed no detectable pathology.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7473553     DOI: 10.1021/jm00021a015

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

1.  Oral calcitonin.

Authors:  Michael J Maricic
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

2.  Intestinal absorption of octreotide using trimethyl chitosan chloride: studies in pigs.

Authors:  M Thanou; J C Verhoef; J H Verheijden; H E Junginger
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

Review 3.  Lessons learned from the clinical development of oral peptides.

Authors:  Morten Asser Karsdal; Bente Juul Riis; Nozer Mehta; William Stern; Ehud Arbit; Claus Christiansen; Kim Henriksen
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

4.  Population pharmacokinetic-pharmacodynamic modeling of subcutaneous and pulmonary insulin in rats.

Authors:  Mathangi Gopalakrishnan; Sandra Suarez; Anthony J Hickey; Jogarao V S Gobburu
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-08       Impact factor: 2.745

5.  Immediate and short-term cellular and biochemical responses to pulmonary single-dose studies of insulin and H-MAP.

Authors:  L Garcia-Contreras; D Sarubbi; E Flanders; D O'Toole; J Smart; C Newcomer; A J Hicke
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

6.  Facilitation of pulmonary insulin absorption by H-MAP: pharmacokinetics and pharmacodynamics in rats.

Authors:  S Suarez; L Garcia-Contreras; D Sarubbi; E Flanders; D O'Toole; J Smart; A J Hickey
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

7.  Heparin absorption across the intestine: effects of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate in rat in situ intestinal instillations and in Caco-2 monolayers.

Authors:  D Brayden; E Creed; A O'Connell; H Leipold; R Agarwal; A Leone-Bay
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

8.  Transcellular and lipophilic complex-enhanced intestinal absorption of human growth hormone.

Authors:  S J Wu; J R Robinson
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

9.  Pharmacokinetics and pharmacodynamics of oral heparin solid dosage form in healthy human subjects.

Authors:  Shaker A Mousa; Fuming Zhang; Ahmad Aljada; Seema Chaturvedi; Majde Takieddin; Haifeng Zhang; Lianli Chi; M Cristina Castelli; Kristen Friedman; Michael M Goldberg; Robert J Linhardt
Journal:  J Clin Pharmacol       Date:  2007-12       Impact factor: 3.126

10.  Basics and recent advances in peptide and protein drug delivery.

Authors:  Benjamin J Bruno; Geoffrey D Miller; Carol S Lim
Journal:  Ther Deliv       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.